Piper Sandler Maintains Overweight on Teladoc Health, Lowers Price Target to $10
Portfolio Pulse from Benzinga Newsdesk
Piper Sandler analyst Jessica Tassan maintains an Overweight rating on Teladoc Health (NYSE:TDOC) but lowers the price target from $25 to $10.
August 06, 2024 | 1:07 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Piper Sandler maintains an Overweight rating on Teladoc Health but significantly lowers the price target from $25 to $10.
The significant reduction in the price target from $25 to $10 suggests a negative outlook on Teladoc Health's future performance, which is likely to put downward pressure on the stock price in the short term despite the maintained Overweight rating.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100